Related Articles
CD55 and CD59 expression protects HER2‑overexpressing breast cancer cells from trastuzumab‑induced complement‑dependent cytotoxicity
FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2‑positive breast cancer cells
Synergistic antitumor effect of the anti‑ErbB2 antibodies trastuzumab and H2‑18 on trastuzumab‑resistant gastric cancer cells
HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells
Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo